NeutriSci International Inc. announced that is has successfully completed the R&D of a newly developed effervescent functional mushroom tablet product for online sales in Europe and North America. The new product line will consist of Reishi, Chaga, Cordyceps, Lion's Mane, Tremelle, and Turkey Tail mushrooms while containing a proprietary blend of CBD, CBN and or CBG; designed to complement the already potent health benefits of functional mushrooms. Packaging for the product is currently being finalized; designed around several flavor profiles, including citrus and berry. Functional mushrooms are packed with antioxidants and nutritional value. They are widely consumed due to their medicinal properties and superfood benefits. Furthermore, increasing acceptability of mushroom for medicinal properties is boosting the sales and profit of the players currently operating in the market, which in turn, is expected to further drive the market growth for functional mushrooms. Mushrooms that support immune health have benefited since the start of the COVID-19 pandemic, with high interest from food, beverage, and nutritional supplement manufacturers, which has carried over to the entire mushroom category.